1K5N image
Entry Detail
PDB ID:
1K5N
Keywords:
Title:
HLA-B*2709 BOUND TO NONA-PEPTIDE M9
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2001-10-11
Release Date:
2002-10-30
Method Details:
Experimental Method:
Resolution:
1.09 Å
R-Value Free:
0.14
R-Value Work:
0.12
R-Value Observed:
0.12
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:major histocompatibility complex molecule HLA-B*2709
Chain IDs:A
Chain Length:276
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:beta-2-microglobulin, light chain
Chain IDs:B
Chain Length:100
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:nonameric model peptide m9
Chain IDs:C
Chain Length:9
Number of Molecules:1
Biological Source:
Ligand Molecules
Primary Citation
HLA-B27 Subtypes Differentially Associated with Disease Exhibit Subtle Structural Alterations
J.Biol.Chem. 277 47844 47853 (2002)
PMID: 12244049 DOI: 10.1074/jbc.M206392200

Abstact

The reasons for the association of the human major histocompatibility complex protein HLA-B27 with spondyloarthropathies are unknown. To uncover the underlying molecular causes, we determined the crystal structures of the disease-associated B*2705 and the nonassociated B*2709 subtypes complexed with the same nonapeptide (GRFAAAIAK). Both differ in only one residue (Asp(116) and His(116), respectively) in the F-pocket that accommodates the peptide C terminus. Several different effects of the Asp(116) --> His replacement are observed. The bulkier His(116) induces a movement of peptide C-terminal pLys(9), allowing the formation of a novel salt bridge to Asp(77), whereas the salt bridge between pLys(9) and Asp(116) is converted into a hydrogen bond with His(116). His(116) but not Asp(116) adopts two alternative conformations, one of which leads to breakage of hydrogen bonds. Water molecules near residue 116 differ with regard to number, position, and contacts made. Furthermore, F-pocket atoms exhibit higher B-factors in B*2709 than in B*2705, indicating an increased flexibility of the entire region in the former subtype. These changes induce subtle peptide conformational alterations that may be responsible for the immunobiological differences between these HLA-B27 subtypes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures